S. Maddens

Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry

W. Wuyts, M. Schlesser, B. Bondue, 2022, Pulmonary Therapy.

Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry

W. Wuyts, M. Schlesser, B. Bondue, 2019, Respiratory Research.

Baseline clinical characteristics, comorbidities and prescribed medication in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry

W. Wuyts, M. Schlesser, B. Bondue, 2018, BMJ Open Respiratory Research.

Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study

J. V. van Meerbeeck, R. Gosselin, G. van Maele, 2007, Thorax.

Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study

R. Gosselin, K. Tournoy, A. Kelles, 2007, Thorax.